Related Experiment Video
Updated: Sep 7, 2026
Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test
Published on: January 15, 2010
Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL/6 mice: a model for Parkinson's disease
E Sundström1, A Fredriksson, T Archer
1Department of Histology and Neurobiology, Karolinska Institutet, Stockholm, Sweden.
Abstract:
The long-term effect of the parkinsonism inducing neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on pre- and postsynaptic structures of the nigrostriatal and mesolimbic dopamine (DA) system in adult C57BL/6 mice (2 x 40 mg/kg s.c.) was investigated using neurochemical and behavioral methods. It was found that MPTP induced a severe depletion of striatal DA levels (-80%) that persists for 4 weeks after treatment, with less severe effects in nucleus accumbens (-36%) and the olfactory tubercle (-52%). These depletions are associated with decreased tyrosine hydroxylase (TH) activity as determined in vivo and increased turnover of DA. MPTP treatment did not induce any change in the DA2-receptor as determined by [3H]spiperone binding or by two different behavioral tests, i.e. apomorphine-induced climbing and apomorphine-induced stereotypies. No significant weight loss during 4 weeks after MPTP was found. The spontaneous motor activity in these mice was profoundly and persistently depressed (-66%) as a result of the MPTP-induced DA denervation and the motor deficit was completely reversed by L-DOPA treatment. We suggest that MPTP-treated C57BL/6 mice may serve as a suitable model for Parkinson's disease.
Insights
The neurotoxin MPTP severely depletes dopamine in mice, causing persistent motor deficits. L-DOPA treatment reversed these effects, suggesting MPTP-induced Parkinsonism in mice is a viable disease model.
Area of Science:
- Neuroscience
- Pharmacology
- Toxicology
Background:
- Parkinson's disease is a neurodegenerative disorder characterized by dopamine system dysfunction.
- The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is known to induce parkinsonism.
Purpose of the Study:
- To investigate the long-term effects of MPTP on the nigrostriatal and mesolimbic dopamine systems.
- To evaluate MPTP-treated mice as a model for Parkinson's disease.
Main Methods:
- Adult C57BL/6 mice were treated with MPTP.
- Neurochemical assays measured dopamine levels and tyrosine hydroxylase activity.
- Behavioral tests assessed motor activity and dopamine D2-receptor function.
Main Results:
- MPTP caused significant and persistent dopamine depletion in striatum, nucleus accumbens, and olfactory tubercle.
- Tyrosine hydroxylase activity decreased, and dopamine turnover increased.
- Motor activity was profoundly depressed but reversed by L-DOPA; dopamine D2-receptor function remained unchanged.
Conclusions:
- MPTP induces long-lasting dopaminergic neurotoxicity in mice.
- MPTP-treated mice exhibit motor deficits consistent with Parkinson's disease.
- This model is suitable for studying Parkinson's disease pathogenesis and potential therapies.
